Pharmafile Logo
Pharmafocus logo
Advanced Search

schizophrenia

Showing 4 posts of 34 posts found.

Janssen’s Invega wins schizoaffective approval in Europe

January 6, 2011
Sales and Marketing Invega, Janssen, paliperidone ER, schizoaffective disorder, schizophrenia

Janssen’s Invega has become the first drug to be licensed in Europe to treat schizoaffective disorder. European regulators approved Invega …

News

Roche highlights R&D promise after setbacks

December 9, 2010
Research and Development MS, Roche, oncology, personalised medicine, schizophrenia

Roche has presented its pipeline to shareholders to boost confidence that it can sustain the spectacular growth of recent years. …

News

NICE issues schizophrenia commissioning guide

January 14, 2010
NICE, commissioning, schizophrenia

NICE has published a commissioning guide to help primary and secondary care teams recognise, treat and manage adult schizophrenia. The …

News

The management of schizophrenia

October 14, 2003
Sales and Marketing NICE, clinical guidelines, healthcare, schizophrenia

The publication of NICE's clinical guidelines on the management of schizophrenia in December marks a significant milestone – the first …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025